IMRIS ORT300 Removable Operating Room Table, 50-60 Hz Version is intended for use during diagnostic examinations or surgical procedures to support and position a patient.
FDA Recall Z-1218-2018 · Posted None
Advertisement
Recalling FirmDeerfield Imaging, Inc.
Recall StatusTerminated
Product CodeFQO
Date Initiated2018-02-23
Date Terminated2019-08-27
Product Quantity13 units
Reason for Recall
The rotational locking mechanisms on the ORT 200/300 tables fail to operate such that it cannot change states between locked and unlocked.
Firm Action
The firm disseminated their notices on 02/23/2018 by mail and followed with an email on 02/26/2018. The notice stated:
"It has recently come to our attention that the ORT200/300 rotational lock fails to operate such that it cannot change states between locked and unlocked. This may pose a risk of injury to the patient.
To minimize the risk of injury, IMRJS is taking the following corrective actions:
" ORT200 and 300 tables: all customer sites with these tables shall have the rotational lock operation verified and adjusted, if necessary.
IMRIS has identified that your facility has one or more of these OR Tables which require evaluation. Please confirm details on page 2 and return your response to IMRIS. IMRIS Customer Service will contact you to implement this corrective action.
IMRIS recommends these preventive actions:
" Per the OAT Operator Manuals the table should be tested daily in all standard positions and inspected for anomalies including the fit of the covers, tabletops, headrest, pendant connection and rotation.
" During usage, verify the table is locked by manually pushing the table to make sure it does not move rotationally.
" If the rotational lock is observed to be not functioning properly, please contact IMRIS Customer Service.
The appropriate competent authorities have been notified of this corrective action. IMRIS is committed to patient and user safety, and apologizes for any inconvenience that this may cause. Please contact customer support via our service line at 1-866-475-0525 or Email: customersupport@imris. com if you have any questions or concerns."
Root Cause
Under Investigation by firm
Distribution Pattern
US, Canada, China, Sweden, Germany, Japan, Qatar, France, Audtralia
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement